^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

BRY812

i
Other names: BRY812
News
Trials
Company:
Zhejiang Hisun
Drug class:
Microtubule inhibitor, LIV-1-targeted antibody-drug conjugate
Related drugs:
News
Trials